XENE Q1 2023 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$49M

Net Income

-$42M

EPS (Diluted)

$-0.63

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$37M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$720M

Total Liabilities

$33M

Stockholders' Equity

$687M

Cash & Equivalents

$70M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$9M	-100.0%
Gross Profit	$0	-$11M	+100.0%
Operating Income	-$49M	-$17M	-182.4%
Net Income	-$42M	-$20M	-112.1%